Cricut, Inc. (CRCT) Spending and interest coverage
- R&D / revenue · 12 months: Value 9.79%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 3.89%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 9.79% | Research and development expense / revenue. Period ending 2026-06-30. $67.56M ÷ $689.79M × 100 ≈ 9.79% |
| Stock-based compensation / revenue · 12 months | 3.89% | Share-based compensation / revenue. Period ending 2026-06-30. $26.85M ÷ $689.79M × 100 ≈ 3.89% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 67.56M USD | Research and Development Expense |
| Revenue | 689.79M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 26.85M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 106.89M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $67.56M | $689.79M | $26.85M | $106.89M | (m) | 9.79% | 3.89% | (m) | (m) |
| 2026-03-31 | $67.47M | $705.62M | $30.80M | $89.58M | (m) | 9.56% | 4.37% | (m) | (m) |
| 2025-12-31 | $66.52M | $708.78M | $34.79M | $96.03M | $567.00K | 9.39% | 4.91% | 169.37× | Reported |
| 2025-09-30 | $65.28M | $714.49M | $39.33M | $95.97M | (m) | 9.14% | 5.51% | (m) | (m) |
| 2025-06-30 | $63.65M | $711.95M | $43.83M | $83.92M | (m) | 8.94% | 6.16% | (m) | (m) |
| 2025-03-31 | $61.20M | $707.78M | $44.76M | $80.25M | (m) | 8.65% | 6.32% | (m) | (m) |
| 2024-12-31 | $60.40M | $712.54M | $45.07M | $76.11M | $326.00K | 8.48% | 6.32% | 233.47× | Reported |
| 2024-09-30 | $59.40M | $734.48M | $45.79M | $78.75M | (m) | 8.09% | 6.23% | (m) | (m) |
| 2024-06-30 | $60.07M | $741.49M | $46.40M | $91.84M | $325.00K | 8.10% | 6.26% | 282.59× | Reported |
| 2024-03-31 | $62.10M | $751.31M | $47.66M | $84.66M | $325.00K | 8.27% | 6.34% | 260.50× | Reported |
| 2023-12-31 | $65.05M | $765.15M | $47.33M | $69.98M | $323.00K | 8.50% | 6.19% | 216.67× | Reported |
| 2023-09-30 | $67.64M | $814.66M | $45.28M | $64.56M | (m) | 8.30% | 5.56% | (m) | (m) |
| 2023-06-30 | $70.48M | $816.75M | $44.07M | $58.30M | (m) | 8.63% | 5.40% | (m) | (m) |
| 2023-03-31 | $74.19M | $822.74M | $42.58M | $59.08M | (m) | 9.02% | 5.18% | (m) | (m) |
| 2022-12-31 | $76.91M | $886.30M | $41.12M | $79.95M | (m) | 8.68% | 4.64% | (m) | (m) |
| 2022-09-30 | $82.31M | $993.36M | $40.76M | $94.70M | (m) | 8.29% | 4.10% | (m) | (m) |
| 2022-06-30 | $84.09M | $1.08B | $37.64M | $115.03M | (m) | 7.81% | 3.50% | (m) | (m) |
| 2022-03-31 | $84.65M | $1.23B | $35.35M | $159.15M | (m) | 6.90% | 2.88% | (m) | (m) |
| 2021-12-31 | $79.81M | $1.31B | $38.07M | $192.41M | (m) | 6.11% | 2.91% | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $38.93M | $959.03M | $9.48M | $200.51M | (m) | 4.06% | 0.99% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $26.67M | $486.55M | $1.84M | $53.56M | (m) | 5.48% | 0.38% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.